Larimar Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

라리마 테라퓨틱스NASDAQ:LRMR · Nasdaq · Healthcare

$2.96-3.27%

2026-10-02 close

Larimar Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$91M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy